Type 2 diabetes
Biguanides, sulfonylureas, DPP-4 inhibitors and combinations.
Therapeutic area
Diabetes & metabolic care
Oral antidiabetics and metabolic therapies built around dependable glycaemic control and the long treatment horizons diabetes care demands.
01 — Why it matters
Care that
cannot pause.
Diabetes management is a lifelong commitment. Interruptions in supply translate immediately into clinical risk, which is why our metabolic portfolio is planned around forecastable volumes and buffer stock at European level.
We work with partners whose production lines are qualified for high-volume solid dosage forms, allowing us to serve both tender-driven and private markets without compromising consistency.
Dosage forms
- Immediate-release tablets
- Prolonged-release tablets
- Fixed-dose combinations
02 — Focus
Where we
concentrate.
Product selection within diabetes & metabolic care follows clinical demand, not catalogue size.
Glycaemic control
Therapies supporting stable long-term metabolic outcomes.
Comorbidity care
Products that align with cardiovascular and renal treatment needs.
Adherence formats
Combination formats that reduce daily pill burden.
Other areas
Availability
Ask about diabetes & metabolic care
in your market.
We confirm molecule-level availability, dossier status and registration options per country.
Start an enquiry